Results 21 to 30 of about 7,499,902 (307)
Long-acting microneedle formulations
Advanced Drug Delivery Reviews, 2023 The minimally-invasive and painless nature of microneedle (MN) application has enabled the technology to obviate many issues with injectable drug delivery. MNs not only administer therapeutics directly into the dermal and ocular space, but they can also control the release profile of the active compound over a desired period.
Lalitkumar K. Vora +13 more
openaire +3 more sources
Long-acting beta2-agonists for chronic obstructive pulmonary disease. [PDF]
, 2013 BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a respiratory disease that causes progressive symptoms of breathlessness, cough and mucus build-up.
Walters, JA +5 more
core +1 more source
Long-Acting Reversible Contraception
Obstetrics & Gynecology, 2022 Long-acting reversible contraceptive (LARC) methods are effective options for pregnancy prevention. Currently available products in the United States include an etonogestrel implant, a copper intrauterine device (IUD), and several levonorgestrel IUDs. With increasing prevalence and duration of use, our understanding of efficacy, risks, and benefits has
Baker, Courtney C, Creinin, Mitchell D
openaire +4 more sources
Journal of Pharmaceutical Analysis, 2015 A stable HMG-CoA reductase (HMGR) reaction in vitro was developed by a sensitive, selective and precise liquid chromatography–tandem mass spectrometry (LC–MS/MS) method.
Jing Wang +7 more
doaj +1 more source
Long acting growth hormone (LAGH), an update
Frontiers in Pediatrics, 2023 In 1957, Maurice Raben at Yale was able to isolate and purify growth hormone from cadaveric pituitary glands. Pituitary growth hormone was the only way to treat children with growth hormone (GH) deficiency, until 1985 when recombinant GH became available
Margaret Steiner Grillo +2 more
doaj +1 more source
Combination inhaled steroid and long-acting beta-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease (Review) [PDF]
, 2011 Background The long-acting bronchodilator tiotropium and single inhaler combination therapy of inhaled corticosteroids and long-acting beta(2)-agonists are both commonly used for maintenance treatment of chronic obstructive pulmonary disease.
Christopher J Cates +3 more
core +1 more source
European Psychiatry, 2021 Introduction Long-acting injectable antipsychotics (LAIs) can reduce relapse and hospitalization risk but they are not widely used in first psychotic episode (FEP) patientes. Objectives To examine the effcacy of two of the most used second generation
P. Gil Lopez +3 more
doaj +1 more source
Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma [PDF]
, 2011 Asthma patients who continue to experience symptoms despite being on regular inhaled corticosteroids (ICS) represent a management challenge. Long-acting beta2-agonists (LABA) or anti-leukotrienes (LTRA) are two treatment options that could be considered ...
Christopher J Cates +5 more
core +1 more source
Use of short‐acting vs. long‐acting loop diuretics after heart failure hospitalization
ESC Heart Failure, 2022 Aims Furosemide, a short‐acting loop diuretic (SD), is the dominant agent prescribed for heart failure (HF) in clinical practice. However, accumulating data suggests that long‐acting loop diuretics (LD), such as torsemide or azosemide, might have more ...
Shohei Imaeda +11 more
doaj +1 more source
Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease. [PDF]
, 2011 Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Developments in the understanding of COPD have led to standard guidelines for diagnosis, treatment, and spirometry assessments, which have in turn ...
James Donohue +5 more
core +1 more source